BioRegenx, Inc.
BRGX
$0.0115
-$0.0005-4.17%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -266.90K | -18.40M | -394.90K | -3.55M | -3.15M |
| Total Depreciation and Amortization | 12.40K | 574.50K | 574.50K | 870.20K | 500.50K |
| Total Amortization of Deferred Charges | 1.50K | 14.30K | 8.60K | 24.80K | 11.20K |
| Total Other Non-Cash Items | 91.30K | 17.66M | -260.50K | 2.20M | 2.29M |
| Change in Net Operating Assets | 199.30K | 139.60K | 41.10K | 138.30K | 245.10K |
| Cash from Operations | 37.70K | -11.40K | -31.20K | -318.60K | -104.30K |
| Capital Expenditure | -- | 0.00 | 0.00 | 399.00K | -189.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | 0.00 | 1.40K | 1.40K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 2.70K | 0.00 | 18.45M | -2.70K |
| Cash from Investing | -- | 2.70K | 0.00 | 18.85M | -190.60K |
| Total Debt Issued | -- | 1.50K | 56.80K | -205.50K | 300.00K |
| Total Debt Repaid | -10.40K | -8.50K | -10.30K | 62.00K | -17.40K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -18.44M | -- |
| Cash from Financing | -10.40K | -6.90K | 46.40K | -18.58M | 282.60K |
| Foreign Exchange rate Adjustments | -2.10K | 4.00K | -2.60K | 500.00 | 1.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 25.20K | -11.70K | 12.70K | -56.80K | -11.20K |